Tucson – October 14, 2026 -- Siensmetrica, Inc. has changed its name to Tessa AI, Inc. effective October 7, aligning the company with the brand of its AI research evaluation platform, Tessa, and signaling a push beyond paper scoring into tools for the full lifecycle of scientific research.

Oxford – October 14, 2026 -- Brainomix has partnered with the Pulmonary Fibrosis Foundation (PFF) to test how patients and caregivers respond when its FDA-cleared, CE-marked e-Lung quantitative CT analysis is built into clinicians' assessment workflow for pulmonary fibrosis (PF) and other fibrotic interstitial lung diseases (ILD).

Toronto – October 14, 2026 -- Deloitte Consulting LLP will demonstrate live how AI-enabled case intake can handle incoming adverse event data in pharmacovigilance during an Xtalks webinar on Wednesday, October 28, 2026, at 1pm EDT (10am PDT).

Atlanta – October 14, 2026 -- Solv Wellness, a women's health company focused on perimenopause and menopause, has appointed Christine Vaccaro, DO, FACOG, MSCP, as its first Chief Medical Officer, effective immediately.

Vaccaro will advise the company on its menopause education strategy and support educational initiatives for patients and healthcare professionals. She will also contribute to patient and clinician resources and represent the company in select media, speaking and educational programs.

Dallas – October 14, 2026 -- Nanoscope Therapeutics has appointed Troy Short, who built the global supply chain for Zolgensma across more than 30 countries at AveXis, as Senior Vice President of Manufacturing and Supply Chain while its lead gene therapy MOGENRY is under regulatory review in the United States and Japan.

Cambridge – – October 14, 2026 -- TRI has released OPRA 26.2, an update to its risk-based quality management (RBQM) platform that adds an AI agent, RiskIQ, to draft protocol risk assessments. The release is available from October 14, 2026.

Washington – October 14, 2026 -- Danaher Corporation (NYSE: DHR) has launched a collaboration with NVIDIA to combine its scientific instruments, automation technologies, laboratory workflow software and domain expertise with NVIDIA accelerated computing and AI, targeting faster movement from AI prediction to experimental evidence.

Geneva – October 14, 2026 -- MindMaze Therapeutics (SIX: MMTX) reported that home-based rehabilitation with its MindMotion platform raised total motor-training dose by a median factor of 3.0 versus usual outpatient therapy alone, with 84% of active training completed without direct therapist supervision.

The multi-site program, run with Vibra Healthcare, was presented at the American Congress of Rehabilitation Medicine (ACRM) in Washington, DC. The data arrive ahead of the company's MindMotion Lite launch, expected by year-end 2026.

Dallas – October 14, 2026 -- Ten Taiwanese hospitals and health-tech companies used Taiwan Expo USA 2026 in Dallas to probe the U.S. market, arriving at stages ranging from seeking first partners to operating FDA-cleared products with American customers.

Sydney – October 13, 2026 -- Osara Health has partnered with Medibank, one of Australia's largest private health insurers, to offer its Cancer Coach program to more than 4 million Medibank customers, subject to eligibility. Eligible members living with cancer can join from 14 October 2026.